ClinicalTrials.Veeva

Menu

Driving Performance of People With Parkinson's Using Autonomous In-Vehicle Technologies

University of Florida logo

University of Florida

Status

Completed

Conditions

Parkinson Disease

Treatments

Other: PD Drivers Using AV Technologies On-road

Study type

Interventional

Funder types

Other
Other U.S. Federal agency

Identifiers

NCT04660500
90IFRE0035-03-00 (Other Grant/Funding Number)
IRB202002321

Details and patient eligibility

About

For drivers with Parkinson's Disease (PD), autonomous in-vehicle technologies may help mitigate functional deficits, improve driving performance, decrease driving errors and enhance their ability to stay on the road. Using a pretest/posttest design the investigators will quantify the use of In-vehicle Information Systems (IVIS) and Advanced Driver Assistance Systems (ADAS) during driving to illustrate how IVIS and ADAS may affect driving, and provide recommendations to drivers with PD, the clinical community and industry.

Enrollment

112 patients

Sex

All

Ages

35 to 85 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Subjects diagnosed by a neurologist/ movement disorder specialist with clinically probable PD by Movement Disorders Society (MDS) criteria 25
  2. Has mild or moderate disease severity, based on the MDS-Unified Parkinson's Disease Rating Scale for motor symptoms (hereafter referred to as the UPDRS section 3) in the on state of medications (i.e., one hour of taking PD medications) and the Modified Hoehn and Yahr disease severity scale
  3. Is representative of one of two PD groups based on age, i.e., participants with symptom onset between 35-64 years of age (younger onset), or participants with symptom onset between ages 65- 85 years (older onset)
  4. Currently driving with a valid license
  5. Meets the Florida state requirement for visual acuity of at least 20/50 in one eye, if one eye is blind or 20/200 or worse the other eye must be 20/40 or better (20/40 in at least one eye) and field of vision (130 degrees or more)
  6. Lives independently in the community
  7. Proficient in reading/speaking English
  8. A Montreal Cognitive Assessment (MoCA) score of 20 or higher

Exclusion criteria

  1. Concurrent neurological conditions (e.g., stroke, seizures; dementia)
  2. Severe psychiatric (e.g., psychoses/ significant anxiety) or physical conditions (e.g., missing limbs) precluding full participation
  3. Use of psychotropic medications having adverse effect on mental/physical functioning
  4. Severe, unpredictable motor fluctuations
  5. Severe sleep difficulties.

Trial design

Primary purpose

Supportive Care

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

112 participants in 1 patient group

PD Drivers Using AV Technologies On-road
Experimental group
Description:
Each driver will drive on-road, everybody will be exposed to two drives (Drive 1, Drive 2) one drive with and the other without in-vehicle technology. The order of technology (with vs. without IVIS or ADAS) and the order of the routes (Drive 1 vs. Drive 2) will be randomly allocated to control for order effects.
Treatment:
Other: PD Drivers Using AV Technologies On-road

Trial contacts and locations

1

Loading...

Central trial contact

Mary Jeghers

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems